1. Home
  2. CTXR vs INTT Comparison

CTXR vs INTT Comparison

Compare CTXR & INTT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CTXR
  • INTT
  • Stock Information
  • Founded
  • CTXR 2007
  • INTT 1981
  • Country
  • CTXR United States
  • INTT United States
  • Employees
  • CTXR N/A
  • INTT N/A
  • Industry
  • CTXR Biotechnology: Pharmaceutical Preparations
  • INTT Semiconductors
  • Sector
  • CTXR Health Care
  • INTT Technology
  • Exchange
  • CTXR Nasdaq
  • INTT Nasdaq
  • Market Cap
  • CTXR 84.9M
  • INTT 80.2M
  • IPO Year
  • CTXR N/A
  • INTT 1997
  • Fundamental
  • Price
  • CTXR $0.41
  • INTT $7.44
  • Analyst Decision
  • CTXR Strong Buy
  • INTT Buy
  • Analyst Count
  • CTXR 2
  • INTT 2
  • Target Price
  • CTXR $5.00
  • INTT $13.00
  • AVG Volume (30 Days)
  • CTXR 1.1M
  • INTT 47.1K
  • Earning Date
  • CTXR 08-12-2024
  • INTT 11-01-2024
  • Dividend Yield
  • CTXR N/A
  • INTT N/A
  • EPS Growth
  • CTXR N/A
  • INTT N/A
  • EPS
  • CTXR N/A
  • INTT 0.38
  • Revenue
  • CTXR N/A
  • INTT $122,640,000.00
  • Revenue This Year
  • CTXR N/A
  • INTT $7.93
  • Revenue Next Year
  • CTXR N/A
  • INTT $5.15
  • P/E Ratio
  • CTXR N/A
  • INTT $19.26
  • Revenue Growth
  • CTXR N/A
  • INTT N/A
  • 52 Week Low
  • CTXR $0.34
  • INTT $6.28
  • 52 Week High
  • CTXR $1.07
  • INTT $14.35
  • Technical
  • Relative Strength Index (RSI)
  • CTXR 38.61
  • INTT 56.53
  • Support Level
  • CTXR $0.34
  • INTT $6.86
  • Resistance Level
  • CTXR $0.41
  • INTT $7.89
  • Average True Range (ATR)
  • CTXR 0.04
  • INTT 0.32
  • MACD
  • CTXR 0.00
  • INTT 0.07
  • Stochastic Oscillator
  • CTXR 36.59
  • INTT 58.72

About CTXR Citius Pharmaceuticals Inc.

Citius Pharmaceuticals Inc is a biopharmaceutical company with a focus on anti-infectives in adjunct cancer care, prescription products, and stem cell therapy. It is currently advancing four proprietary product candidates: LYMPHIR for the treatment of patients with persistent or recurrent cutaneous T-cell lymphoma . Mino-Lok, which is an antibiotic lock solution used to treat patients with catheter-related bloodstream infections; Mino-Wrap, a liquifying gel-based wrap for reduction of tissue expander infections following breast reconstructive surgeries; Halo-Lido, a topical formulation that is intended to provide anti-inflammatory and anesthetic relief to persons suffering from hemorrhoids; NoveCite, a mesenchymal stem cell therapy for the treatment of acute respiratory distress syndrome.

About INTT inTest Corporation

inTest Corp is a supplier of test and process solutions for use in manufacturing and testing across a range of markets including automotive, defense/aerospace, industrial, medical, semiconductor and telecommunications. The company manages its business as three operating segments which is also their reporting units that includes Electronic Test, Environmental Technologies and Process Technologies. Electronic Test (which includes semiconductor test equipment, flying probe and in-circuit testers), Environmental Technologies (which includes its thermal test, process and storage products) and Process Technologies (which includes induction heating and video imaging products). They operate their business worldwide and sells its products both domestically and internationally.

Share on Social Networks: